Cynthia Aranow

Cynthia Aranow

UNVERIFIED PROFILE

Are you Cynthia Aranow?   Register this Author

Register author
Cynthia Aranow

Cynthia Aranow

Publications by authors named "Cynthia Aranow"

Are you Cynthia Aranow?   Register this Author

79Publications

2529Reads

-Profile Views

Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

J Rheumatol 2019 May 15;46(5):492-500. Epub 2019 Jan 15.

From the Rheumatology/Division of Neuro and Inflammation Sciences, Department of Clinical and Experimental Medicine, Linköping University, Linköping; Department of Medicine, Unit of Rheumatology, Karolinska Institutet and Karolinska University Hospital, Stockholm; Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund; Unit for Clinical Therapy Research (ClinTRID), Karolinska University, Stockholm, Sweden; Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario; Division of Rheumatology, Centre Hospitalier Universitaire (CHU) de Québec - Université Laval, Quebec City, Quebec; Division of Rheumatology, Cumming School of Medicine - University of Calgary, Calgary, Alberta; Division of Rheumatology, Department of Medicine, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Department of Medicine and Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham; Centre for Rheumatology Research, University College, London; Lupus Research Unit, The Rayne Institute, St. Thomas' Hospital, King's College London School of Medicine, London; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, The University of Manchester and UK National Institute for Health Research (NIHR) Manchester Biomedical Research Centre, Manchester University Foundation Trust, Manchester, UK; Cedars-Sinai/David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Medicine, State University of New York (SUNY) Downstate Medical Center, Brooklyn, New York; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama; Department of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Feinstein Institute for Medical Research, Manhasset, New York; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina; Autoimmunity Institute, Allegheny Health Network, Pittsburgh, Pennsylvania; Northwestern University and Feinberg School of Medicine, Chicago, Illinois; Division of Rheumatology, Emory University School of Medicine, Atlanta, Georgia; University of California San Diego School of Medicine, La Jolla, California; Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina; Division of Rheumatology, Columbia University Medical Center, New York, New York, USA; Department of Rheumatology, Center for Rheumatology Research Fossvogur Landspitali University Hospital, Reyjkavik, Iceland; Autoimmune Disease Unit, Department of Internal Medicine, Hospital Universitario Cruces, BioCruces Health Research Institute, University of the Basque Country, Barakaldo; Josep Font Autoimmune Diseases Laboratory, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Copenhagen Lupus and Vasculitis Clinic, Centre for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Department of Rheumatology, Kantousspital, Schaffhausen, Switzerland.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.180713
Publisher Site
http://dx.doi.org/10.3899/jrheum.180713DOI Listing
May 2019

Patterns of ANA+ B cells for SLE patient stratification.

JCI Insight 2019 May 2;4(9). Epub 2019 May 2.

Center of Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York, USA.

View Article

Download full-text PDF

Source
https://insight.jci.org/articles/view/127885
Publisher Site
http://dx.doi.org/10.1172/jci.insight.127885DOI Listing
May 2019

Loss of an IgG plasma cell checkpoint in patients with lupus.

J Allergy Clin Immunol 2019 Apr 13;143(4):1586-1597. Epub 2018 Nov 13.

Center of Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00916749183158
Publisher Site
http://dx.doi.org/10.1016/j.jaci.2018.10.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451885PMC
April 2019

Construction of a frailty index as a novel health measure in systemic lupus erythematosus.

J Rheumatol 2019 Apr 15. Epub 2019 Apr 15.

Department of Medicine, Division of Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; Division of Geriatric Medicine, Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea;Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico; Cedars-Sinai/David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; Divisions of Rheumatology and Clinical Epidemiology, Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY, USA; Division of Rheumatology, CHU de Québec et Université Laval, Quebec City, Canada; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, ON, Canada; Arthritis Research UK Epidemiology Unit, Faculty of Biology Medicine and Health, Manchester Academic Health Sciences Center, The University of Manchester, and NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Center Manchester, UK; Center for Rheumatology, Department of Medicine, University College London, UK; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Lupus Research Unit, The Rayne Institute, St Thomas' Hospital, King's College London School of Medicine, UK, London, UK; Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA; Northwestern University and Feinberg School of Medicine, Chicago, IL, USA; Lupus Center of Excellence, Allegheny Health Network, Pittsburgh, PA, USA; Lanarkshire Center for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland UK; Feinstein Institute for Medical Research, Manhasset, NY, USA; Autoimmune Diseases Research Unit, Department of Internal Medicine, BioCruces Health Research Institute, Hospital Universitario Cruces, University of the Basque Country, Barakaldo, Spain; Emory University School of Medicine, Division of Rheumatology, Atlanta, Georgia, USA Division of Rheumatology, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey; Unit for clinical therapy research (ClinTRID), Karolinska Institute, Stockholm, Sweden; Department of Clinical Sciences Lund, Rheumatology, Lund University, Lund, Sweden. Josep Font Autoimmune Diseases Laboratory, IDIBAPS, Department of Autoimmune Diseases, Hospital Clínic, Barcelona, Spain; Medical University of South Carolina, Charleston, South Carolina, USA; UCSD School of Medicine, La Jolla, CA, USA; Copenhagen Lupus and Vasculitis Clinic, 4242, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; University of Manitoba, Winnipeg, Manitoba, Canada; Hospital for Joint Diseases, NYU, Seligman Center for Advanced Therapeutics, New York NY; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada. Funding for this work was provided by the Nova Scotia Health Authority Research Fund. Dr. Sang-Cheol Bae's work was supported in part by NRF-2017M3A9B4050335, Republic of Korea. Dr. Caroline Gordon's work was supported by Lupus UK and the NIHR /Wellcome Trust Clinical Research Facility. The Montreal General Hospital Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research. Dr. Clarke holds The Arthritis Society Chair in Rheumatic Diseases at the University of Calgary. Dr. Paul R. Fortin presently holds a tier 1 Canada Research Chair on Systemic Autoimmune Rheumatic Diseases at Université Laval, and part of this work was done while he was still holding a Distinguished Senior Investigator of The Arthritis Society. Dr. Bruce is a National Institute for Health Research (NIHR) Senior Investigator and is supported by Arthritis Research UK, the NIHR Manchester Biomedical Centre and the NIHR/Wellcome Trust Manchester Clinical Research Facility. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. Dr Isenberg and Dr Rahman are supported by and supported by the National Institute for Health, Research University College London Hospitals Biomedical Research Center. The Hopkins Lupus Cohort is supported by the NIH (grant AR43727 and 69572). Dr. Mary Anne Dooley's work was supported by the NIH (grant RR00046). Dr. Ramsey-Goldman's work was supported by the NIH (grants 5UL1TR001422-02, formerly 8UL1TR000150 and UL-1RR-025741, K24-AR-02318, and P60AR064464 formerly P60-AR- 48098). Dr. Ruiz-Irastorza is supported by the Department of Education, Universities and Research of the Basque Government. Dr. Soren Jacobsen is supported by the Danish Rheumatism Association (A3865) and the Novo Nordisk Foundation (A05990). Dr. John G. Hanly is supported by the Canadian Institutes of Health Research (grant MOP-88526). Address Correspondence to: Dr. John G Hanly, Division of Rheumatology, Nova Scotia Rehabilitation Centre (2nd Floor), 1341 Summer Street, Halifax, Nova Scotia, Canada, B3H 4K4.Email:

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.181338
Publisher Site
http://dx.doi.org/10.3899/jrheum.181338DOI Listing
April 2019

Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment.

JCI Insight 2019 Jan 10;4(1). Epub 2019 Jan 10.

Center for Neurosciences, Feinstein Institute for Medical Research and Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.

View Article

Download full-text PDF

Source
https://insight.jci.org/articles/view/124002
Publisher Site
http://dx.doi.org/10.1172/jci.insight.124002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485360PMC
January 2019

Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines.

Arthritis Res Ther 2018 07 5;20(1):133. Epub 2018 Jul 5.

Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Bulfinch 165, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-018-1634-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034317PMC
July 2018

Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.

J Rheumatol 2018 Mar 15;45(3):393-396. Epub 2018 Jan 15.

From The Research Institute of the McGill University Health Centre, Montreal; Université de Laval, Service de rheumatologie, Quebec City, Quebec; Toronto Western Hospital, Toronto, Ontario; Dalhousie University and Capital Health, Halifax, Nova Scotia; University of Manitoba, Winnipeg, Manitoba; Division of Rheumatology, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada; Northwestern University Feinberg School of Medicine, Chicago, Illinois; Johns Hopkins University School of Medicine, Baltimore, Maryland; University of California at San Francisco, Department of Medicine, San Francisco, California; State University of New York-Downstate Medical Center, Brooklyn; The Feinstein Institute for Medical Research, Manhasset, New York; Therapeutic Radiology, Yale University, New Haven, Connecticut, USA; University of Birmingham, College of Medical and Dental Sciences, Birmingham; University College London, Faculty of Medicine, Department of Rheumatology, London, UK; Lund University Hospital, Lund, Sweden; The Hospital for Rheumatic Diseases, Hanyang University, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170652DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834350PMC
March 2018

Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression.

Sci Rep 2017 03 21;7(1):270. Epub 2017 Mar 21.

Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, 11030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41598-017-00290-w
Publisher Site
http://dx.doi.org/10.1038/s41598-017-00290-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412647PMC
March 2017

Remission in SLE: closing in on the target.

Ann Rheum Dis 2015 Dec 28;74(12):2103-6. Epub 2015 Oct 28.

Center for Autoimmune and Musculoskeletal, The Feinstein Institute for Medical Research, Manhasset, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2015-208231DOI Listing
December 2015

A pilot study to determine the optimal timing of the Physician Global Assessment (PGA) in patients with systemic lupus erythematosus.

Authors:
Cynthia Aranow

Immunol Res 2015 Dec;63(1-3):167-9

Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, 11030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12026-015-8712-7
Publisher Site
http://dx.doi.org/10.1007/s12026-015-8712-7DOI Listing
December 2015

Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.

EBioMedicine 2015 Jul 30;2(7):755-64. Epub 2015 May 30.

Autoimmune & Musculoskeletal Disease Center, Feinstein Institute for Medical Research, North Shore LIJ Health System, Manhasset, NY 11030, USA ; Department of Molecular Medicine, Hofstra North Shore-LIJ School of Medicine, Manhasset, NY 11030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2015.05.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534689PMC
July 2015

American College of Rheumatology criteria at inception, and accrual over 5 years in the SLICC inception cohort.

J Rheumatol 2014 May 1;41(5):875-80. Epub 2014 Apr 1.

From the Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada; Instituto Nacional de Ciencias Medicas y Nutricion, Mexico City, Mexico; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK; Department of Rheumatology, Hospital for Rheumatic Diseases and Hanyang University Medical Center, Seoul, Korea; Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, Montreal General Hospital and McGill University Health Centre, Montreal, Quebec, Canada; Centre Hospitalier Universitaire de Québec et Université Laval, Quebec City, Quebec, Canada; Division of Rheumatology, Department of Medicine and Department of Pathology, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada; Centre for Rheumatology Research, University College, London, UK; Cedars-Sinai/David Geffen School of Medicine, University of California, Los Angeles, California, USA; Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York, USA; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute of Inflammation and Repair, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK; Department of Clinical Pharmacology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA; Department of Rheumatology, University Hospital Lund, Lund, Sweden; Division of Rheumatology and Immunology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA; Department of Medicine, Division of Clinical Immunology and Rheumatology, University of Alabama, Birmingham, Alabama, USA; Center for Rheumatology Research, Landspitali University Hospital, Reyjkavik, Iceland; Northwestern University and Feinber

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130704DOI Listing
May 2014

Vitamin D and the immune system.

Authors:
Cynthia Aranow

J Investig Med 2011 Aug;59(6):881-6

Feinstein Institute for Medical Research, Manhasset, NY 11030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2310/JIM.0b013e31821b8755DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166406PMC
August 2011

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

Arthritis Res Ther 2009 28;11(5):R143. Epub 2009 Sep 28.

Division of Rheumatology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/ar2816DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2787265PMC
February 2010

The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.

PLoS One 2010 Feb 16;5(2):e9193. Epub 2010 Feb 16.

Division of Autoimmune and Musculoskeletal Disease, Feinstein Institute for Medical Research, Manhasset, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009193PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821911PMC
February 2010

Glutamate receptor biology and its clinical significance in neuropsychiatric systemic lupus erythematosus.

Rheum Dis Clin North Am 2010 Feb;36(1):187-201, x-xi

Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0889857X0900128
Publisher Site
http://dx.doi.org/10.1016/j.rdc.2009.12.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837540PMC
February 2010

Lupus nephritis: lessons from murine models.

Nat Rev Rheumatol 2010 Jan 1;6(1):13-20. Epub 2009 Dec 1.

Center for Autoimmune and Musculoskeletal Diseases, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrrheum.2009.240
Publisher Site
http://dx.doi.org/10.1038/nrrheum.2009.240DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4120882PMC
January 2010

Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosus.

PLoS One 2009 Jun 2;4(6):e5776. Epub 2009 Jun 2.

The Center for Autoimmune and Musculoskeletal Diseases, Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York, USA.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005776PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2685013PMC
June 2009

Vitamin D in systemic lupus erythematosus.

Curr Opin Rheumatol 2008 Sep;20(5):532-7

Medical University of South Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BOR.0b013e32830a991bDOI Listing
September 2008

Identification of DNA-reactive B cells in patients with systemic lupus erythematosus.

J Immunol Methods 2008 Sep 17;338(1-2):79-84. Epub 2008 Aug 17.

Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System, Manhasset, New York 11030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2008.07.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577778PMC
September 2008

The link between vitamin D deficiency and systemic lupus erythematosus.

Curr Rheumatol Rep 2008 Aug;10(4):273-80

Division of Rheumatology, Medical University of South Carolina, 96 Jonathan Lucas Street, Suite 912, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
August 2008

Neuropsychiatric systemic lupus erythematosus reconsidered.

Nat Clin Pract Rheumatol 2008 Mar;4(3):112-3

Department of Immunology and Rheumatology, Instituto Nacional Nutrición, Mexico City, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncprheum0726DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734405PMC
March 2008

Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis.

Arthritis Rheum 2007 Jun;56(6):1894-903

Albert Einstein College of Medicine, Bronx, New York 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.22594DOI Listing
June 2007

Urinary TWEAK and the activity of lupus nephritis.

J Autoimmun 2006 Dec 24;27(4):242-50. Epub 2007 Jan 24.

Division of Rheumatology, Forchheimer 701N, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2006.12.003DOI Listing
December 2006

Pathogenesis and treatment of systemic lupus erythematosus nephritis.

Curr Opin Rheumatol 2006 Sep;18(5):468-75

Departments of Medicine, Columbia University Medical Center, 1130 St. Nicholas Avenue, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.bor.0000240356.45550.13DOI Listing
September 2006

Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE.

J Exp Med 2006 Sep 21;203(9):2157-64. Epub 2006 Aug 21.

Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20051503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118390PMC
September 2006

Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.

J Clin Invest 2005 Dec;115(12):3428-39

Department of Internal Medicine-Rheumatology, Center for Immunology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-8884, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI23587DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297234PMC
December 2005

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.

N Engl J Med 2005 Nov;353(21):2219-28

Division of Rheumatology, State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa043731DOI Listing
November 2005

Systemic lupus erythematosus disease severity in men and women: a case-control study.

J Rheumatol 2002 Aug;29(8):1674-7

Department of Medicine, New York Medical College, Valhalla, USA.

View Article

Download full-text PDF

Source
August 2002